{"drugs":["Evithrom","Thrombin, Human"],"mono":{"0":{"id":"928844-s-0","title":"Generic Names","mono":"Thrombin, Human"},"1":{"id":"928844-s-1","title":"Dosing and Indications","sub":{"0":{"id":"928844-s-1-4","title":"Adult Dosing","mono":"<ul><li>do not inject systemically as that can lead to extensive intravascular clotting and death<\/li><li><b>Control of hemorrhage:<\/b> apply up to 10 mL TOPICALLY on the surface of the bleeding tissue with or without an Absorbable Gelatin Sponge, USP; amount required depends upon the area of tissue being treated and the method of application<\/li><\/ul>"},"1":{"id":"928844-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>do not inject systemically as that can lead to extensive intravascular clotting and death<\/li><li><b>Control of hemorrhage:<\/b> apply up to 10 mL TOPICALLY on the surface of the bleeding tissue with or without an Absorbable Gelatin Sponge, USP; amount required depends upon the area of tissue being treated and the method of application<\/li><\/ul>"},"3":{"id":"928844-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Control of hemorrhage<br\/><b>Non-FDA Labeled Indications<\/b><br\/>Peptic ulcer with hemorrhage<br\/>"}}},"3":{"id":"928844-s-3","title":"Contraindications\/Warnings","sub":[{"id":"928844-s-3-9","title":"Contraindications","mono":"<ul><li>anaphylaxis or severe systemic reaction to human blood products<\/li><li>arterial bleeding, severe or brisk<\/li><li>direct circulatory injection; extensive intravascular clotting and even death may occur<\/li><\/ul>"},{"id":"928844-s-3-10","title":"Precautions","mono":"<ul><li>human plasma-derived product; theoretical risk of infectious disease transmittal including viruses and Creutzfeldt-Jakob disease<\/li><li>systemic absorption; potential for thrombosis<\/li><li>report all drug-induced infections to Ethicon Customer Support Center 877-384-4266<\/li><\/ul>"},{"id":"928844-s-3-11","title":"Pregnancy Category","mono":"Thrombin: C (FDA)<br\/>"},{"id":"928844-s-3-12","title":"Breast Feeding","mono":"Thrombin: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"928844-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Pruritus (0.7%)<\/li><li><b>Hematologic:<\/b>International normalized ratio, Increased (2.6%), Lymphocyte count abnormal, Decreased (2.6%), Neutrophil count abnormal, Increased (2%), Partial thromboplastin time increased (2.6%), Prothrombin time increased (2.6%)<\/li><\/ul><b>Serious<\/b><br\/><b>Immunologic:<\/b>Anaphylaxis (rare)<br\/>"},"6":{"id":"928844-s-6","title":"Drug Name Info","sub":{"0":{"id":"928844-s-6-17","title":"US Trade Names","mono":"Evithrom<br\/>"},"2":{"id":"928844-s-6-19","title":"Class","mono":"Hemostatic<br\/>"},"3":{"id":"928844-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"}}},"7":{"id":"928844-s-7","title":"Mechanism Of Action","mono":"Thrombin is a protein substance that immediately clots the fibrinogen of the blood directly without the aid of a physiological agent. It is a highly specific protease that convert fibrinogen into fibrin. Thrombin, human is made from pooled human plasma.<br\/>"},"9":{"id":"928844-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>do not inject; for topical application only<br\/><\/li><li><b>Topical<\/b><br\/><ul><li>thaw prior to use in one of 3 ways: at 2 to 8 degrees C in refrigerator, vials thaw within 1 day; at 20 to 25 degrees C (room temperature), vials thaw within 1 hour; at 37 degrees C, 2-mL and 5-mL vials only may be thawed for 10 min MAX (temperature should NOT exceed 37 degrees C)<\/li><li>(using human thrombin alone) sponge or suction target area free of blood before application, do not wipe; flood surface with human thrombin using sterile syringe with small gauge needle; do not sponge clot after administration<\/li><li>(using human thrombin with an Absorbable Gelatin Sponge, USP) transfer human thrombin to a sterile container and immerse sponge; vigorously knead sponge with moistened, gloved fingers until all air is expelled; using moderate pressure, hold sponge in place on target surface with gauze or cotton pledget until hemostasis is achieved<\/li><\/ul><\/li><\/ul>"},"10":{"id":"928844-s-10","title":"Monitoring","mono":"<ul><li>clinical evidence of hemostasis thrombosis and any signs of abnormalities in hemostasis<\/li><li>thrombosis and any signs of abnormalities in hemostasis<\/li><li>transmittal infectious disease, including viruses and Creutzfeldt-Jakob disease<\/li><\/ul>"},"13":{"id":"928844-s-13","title":"Clinical Teaching","mono":"<ul><li>Despite screening and testing, human plasma products carry a remote risk of transmitting infectious agents including Hepatitis A and Parvovirus B19. Risks and benefits should be discussed with patient by healthcare professional.<\/li><li>This drug may cause anaphylactic reactions.<\/li><li>Instruct patient to report signs\/symptoms of thrombosis. Drug may increase risk of thrombosis if absorbed systemically.<\/li><\/ul>"}}}